A blind clinical evaluation committee should, in theory, make data of a randomized clinical trial stronger, not weaker

Saved in:
Bibliographic Details
Published in:Intensive care medicine 2004-05, Vol.30 (5), p.994; author reply 995-994
Main Author: Carlet, J
Format: Article
Language:English
Subjects:
Anti-Infective Agents - therapeutic use
Humans
Protein C - therapeutic use
Randomized Controlled Trials as Topic - methods
Recombinant Proteins - therapeutic use
Sepsis - drug therapy
Sepsis - mortality
Treatment Outcome
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c324t-8c63b0341004269bbe0f7593e93199042b998690b89557a291e307d5d508cb413
cites
container_end_page 994
container_issue 5
container_start_page 994; author reply 995
container_title Intensive care medicine
container_volume 30
creator Carlet, J
description
doi_str_mv 10.1007/s00134-004-2245-1
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71899851</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>703963711</sourcerecordid><originalsourceid>FETCH-LOGICAL-c324t-8c63b0341004269bbe0f7593e93199042b998690b89557a291e307d5d508cb413</originalsourceid><addsrcrecordid>eNpdkUtLBDEQhIMouj5-gBcJHjztaDrJPHKUxRcIXvQcMjO9bnRmoklG0V9vhl1QvHRD81XRRRFyDOwcGCsvAmMgZMaYzDiXeQZbZAZS8Ay4qLbJjAnJM1lIvkf2Q3hJdFnksEv2IGeV4CWbkY9LWnd2aGmTpm1MR_HDdKOJ1g20cX1vY0SkYeXGrp1TO9C4Que_5rQ3r0hbEw11S2qoN0PrevuNf6yit2mG6N3wjH5OBxfpJyadPyQ7S9MFPNrsA_J0ffW4uM3uH27uFpf3WSO4jFnVFKJOKVJayQtV18iWZa4EKgFKpVutVFUoVlcqz0vDFaBgZZu3KV9TSxAH5Gzt--bd-4gh6t6GBrvODOjGoEuokkM-gaf_wBc3-iH9pjkUoEBUEwRrqPEuBI9L_eZtb_yXBqanRvS6EZ3e1VMjetKcbIzHusf2V7GpQPwAWP6E-Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216191381</pqid></control><display><type>article</type><title>A blind clinical evaluation committee should, in theory, make data of a randomized clinical trial stronger, not weaker</title><source>Springer Link</source><creator>Carlet, J</creator><creatorcontrib>Carlet, J</creatorcontrib><identifier>ISSN: 0342-4642</identifier><identifier>EISSN: 1432-1238</identifier><identifier>DOI: 10.1007/s00134-004-2245-1</identifier><identifier>PMID: 15083270</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>Anti-Infective Agents - therapeutic use ; Humans ; Protein C - therapeutic use ; Randomized Controlled Trials as Topic - methods ; Recombinant Proteins - therapeutic use ; Sepsis - drug therapy ; Sepsis - mortality ; Treatment Outcome</subject><ispartof>Intensive care medicine, 2004-05, Vol.30 (5), p.994; author reply 995-994</ispartof><rights>Copyright Springer-Verlag 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c324t-8c63b0341004269bbe0f7593e93199042b998690b89557a291e307d5d508cb413</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15083270$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carlet, J</creatorcontrib><title>A blind clinical evaluation committee should, in theory, make data of a randomized clinical trial stronger, not weaker</title><title>Intensive care medicine</title><addtitle>Intensive Care Med</addtitle><subject>Anti-Infective Agents - therapeutic use</subject><subject>Humans</subject><subject>Protein C - therapeutic use</subject><subject>Randomized Controlled Trials as Topic - methods</subject><subject>Recombinant Proteins - therapeutic use</subject><subject>Sepsis - drug therapy</subject><subject>Sepsis - mortality</subject><subject>Treatment Outcome</subject><issn>0342-4642</issn><issn>1432-1238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNpdkUtLBDEQhIMouj5-gBcJHjztaDrJPHKUxRcIXvQcMjO9bnRmoklG0V9vhl1QvHRD81XRRRFyDOwcGCsvAmMgZMaYzDiXeQZbZAZS8Ay4qLbJjAnJM1lIvkf2Q3hJdFnksEv2IGeV4CWbkY9LWnd2aGmTpm1MR_HDdKOJ1g20cX1vY0SkYeXGrp1TO9C4Que_5rQ3r0hbEw11S2qoN0PrevuNf6yit2mG6N3wjH5OBxfpJyadPyQ7S9MFPNrsA_J0ffW4uM3uH27uFpf3WSO4jFnVFKJOKVJayQtV18iWZa4EKgFKpVutVFUoVlcqz0vDFaBgZZu3KV9TSxAH5Gzt--bd-4gh6t6GBrvODOjGoEuokkM-gaf_wBc3-iH9pjkUoEBUEwRrqPEuBI9L_eZtb_yXBqanRvS6EZ3e1VMjetKcbIzHusf2V7GpQPwAWP6E-Q</recordid><startdate>20040501</startdate><enddate>20040501</enddate><creator>Carlet, J</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7Z</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20040501</creationdate><title>A blind clinical evaluation committee should, in theory, make data of a randomized clinical trial stronger, not weaker</title><author>Carlet, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c324t-8c63b0341004269bbe0f7593e93199042b998690b89557a291e307d5d508cb413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Anti-Infective Agents - therapeutic use</topic><topic>Humans</topic><topic>Protein C - therapeutic use</topic><topic>Randomized Controlled Trials as Topic - methods</topic><topic>Recombinant Proteins - therapeutic use</topic><topic>Sepsis - drug therapy</topic><topic>Sepsis - mortality</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carlet, J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Intensive care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carlet, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A blind clinical evaluation committee should, in theory, make data of a randomized clinical trial stronger, not weaker</atitle><jtitle>Intensive care medicine</jtitle><addtitle>Intensive Care Med</addtitle><date>2004-05-01</date><risdate>2004</risdate><volume>30</volume><issue>5</issue><spage>994; author reply 995</spage><epage>994</epage><pages>994; author reply 995-994</pages><issn>0342-4642</issn><eissn>1432-1238</eissn><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>15083270</pmid><doi>10.1007/s00134-004-2245-1</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0342-4642
ispartof Intensive care medicine, 2004-05, Vol.30 (5), p.994; author reply 995-994
issn 0342-4642
1432-1238
language eng
recordid cdi_proquest_miscellaneous_71899851
source Springer Link
subjects Anti-Infective Agents - therapeutic use
Humans
Protein C - therapeutic use
Randomized Controlled Trials as Topic - methods
Recombinant Proteins - therapeutic use
Sepsis - drug therapy
Sepsis - mortality
Treatment Outcome
title A blind clinical evaluation committee should, in theory, make data of a randomized clinical trial stronger, not weaker
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T13%3A46%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20blind%20clinical%20evaluation%20committee%20should,%20in%20theory,%20make%20data%20of%20a%20randomized%20clinical%20trial%20stronger,%20not%20weaker&rft.jtitle=Intensive%20care%20medicine&rft.au=Carlet,%20J&rft.date=2004-05-01&rft.volume=30&rft.issue=5&rft.spage=994;%20author%20reply%20995&rft.epage=994&rft.pages=994;%20author%20reply%20995-994&rft.issn=0342-4642&rft.eissn=1432-1238&rft_id=info:doi/10.1007/s00134-004-2245-1&rft_dat=%3Cproquest_cross%3E703963711%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c324t-8c63b0341004269bbe0f7593e93199042b998690b89557a291e307d5d508cb413%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=216191381&rft_id=info:pmid/15083270&rfr_iscdi=true